Filing Details
- Accession Number:
- 0001209191-11-025599
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-03 15:05:53
- Reporting Period:
- 2011-05-02
- Filing Date:
- 2011-05-03
- Accepted Time:
- 2011-05-03 15:05:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1046336 | S Kenneth Boger | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02176 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-02 | 5,000 | $24.66 | 121,752 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-02 | 3,614 | $55.57 | 118,138 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-02 | 1,386 | $56.01 | 116,752 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2011-05-02 | 5,000 | $0.00 | 5,000 | $24.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-12-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,660 | Indirect | 401(k) |
| Common Stock | 174,167 | Indirect | Trustee of Trusts |
Footnotes
- Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $55.57 (range $55.06 to $55.88).
- Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $56.01 (range $55.90 to $56.48).
- Kenneth S. Boger is the trustee for trusts established for the benefit of the three adult children of Joshua S. Boger (a director of the issuer).
- Fully vested.
Billionaire Hedge Funds
